Insulin breast cancer connection: Confirmatory data set the stage for better care

Journal of Clinical Oncology

Volumn 29, Issue 1, 2011, Pages 7-10

  DeCensi, Andrea ^a,b   Gennari, Alessandra ^a  

^a GALLIERA HOSPITAL   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ADIPONECTIN; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; C PEPTIDE; ESTROGEN RECEPTOR; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

BLOOD SAMPLING; BODY MASS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVOR; DIABETES MELLITUS; DIET RESTRICTION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG INHIBITION; EDITORIAL; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCREENING TEST; TREATMENT OUTCOME;

BREAST NEOPLASMS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; PROGNOSIS; RISK FACTORS;

EID: 79951997445     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.3022     Document Type: Editorial

References (33)

1. Giovannucci E, Harlan DM, Archer MC, et al: Diabetes and cancer: A consensus report. Diabetes Care 33:1674-1685, 2010
2. Barone BB, Yeh HC, Snyder CF, et al: Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analysis. JAMA 300:2754-2764, 2008
3. Pollak M: Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8:915-928, 2008
4. Boyd DB: Insulin and cancer. Integr Cancer Ther 2:315-329, 2003
5. Belfiore A: The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr Pharm Des 13:671-686, 2007
6. Peairs KS, Barone BB, Snyder CF, et al: Diabetes mellitus and breast cancer outcomes: A systematic review and meta-analysis. J Clin Oncol 29:40-46, 2011
7. Erickson K, Patterson RE, Flatt SW, et al: Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol 29:54-60, 2011
8. Irwin ML, Duggan C, Wang C-Y, et al: Fasting C-peptide levels and death resulting from all causes and breast cancer: The Health, Eating, Activity, and Lifestyle Study. J Clin Oncol 29:47-53, 2011
9. Duggan C, Irwin ML, Xiao L, et al: Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol 29:32-39, 2011
10. Cowie CC, Rust KF, Ford ES, et al: Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 32:287-294, 2009
11. Kabat GC, Kim M, Caan BJ, et al: Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer 125:2704-2710, 2009
12. Goodwin PJ, Ennis M, Pritchard KI, et al: Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study. J Clin Oncol 20:42-51, 2002 (Pubitemid 34032594)
13. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985 (Pubitemid 15018832)
14. Oda N, Imamura S, Fujita T, et al: The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 57:268-273, 2008
15. Mather KJ, Funahashi T, Matsuzawa Y, et al: Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes 57:980-986, 2008
16. Mantzoros C, Petridou E, Dessypris N, et al: Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89:1102-1107, 2004 (Pubitemid 38368397)
17. Goodwin PJ, Ligibel JA, Stambolic V: Metformin in breast cancer: Time for action. J Clin Oncol 27:3271-3273, 2009
18. Pollak M: Metformin and other biguanides in oncology: Advancing the research agenda. Cancer Prev Res (Phila) 3:1060-1065, 2010
19. Vander Heiden MG, Cantley LC, Thompson CB: Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324:1029-1033, 2009
20. Pollak M: Energy metabolism, cancer risk, and cancer prevention. Recent Results Cancer Res 181:51-54, 2009
21. Drugs.com: Metformin. http://www.drugs.com/pro/metformin.html
22. Agarwal N, Rice SP, Bolusani H, et al: Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: A randomized, placebo-controlled, crossover trial. J Clin Endocrinol Metab 95:722-730, 2010
23. Landman GW, Kleefstra N, van Hateren KJ, et al: Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care 33:322-326, 2010
24. Jiralerspong S, Palla SL, Giordano SH, et al: Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 27:3297-3302, 2009
25. DeCensi A, Puntoni M, Goodwin P, et al: Metformin and cancer risk in diabetic patients: A systematic review and meta-analysis. Cancer Prev Res (Phila) [epub ahead of print on October 12, 2010]
26. Alberti KG, Zimmet P, Shaw J: Metabolic syndrome: A new world-wide definition - A consensus statement from the International Diabetes Federation. Diabet Med 23:469-480, 2006
27. Ruderman N, Chisholm D, Pi-Sunyer X, et al: The metabolically obese, normal-weight individual revisited. Diabetes 47:699-713, 1998 (Pubitemid 28201798)
28. Agnoli C, Berrino F, Abagnato CA, et al: Metabolic syndrome and post-menopausal breast cancer in the ORDET cohort: A nested case-control study. Nutr Metab Cardiovasc Dis 20:41-48, 2010
29. Neilson HK, Friedenreich CM, Brockton NT, et al: Physical activity and postmenopausal breast cancer: Proposed biologic mechanisms and areas for future research. Cancer Epidemiol Biomarkers Prev 18:11-27, 2009
30. McTiernan A, Irwin M, Vongruenigen V: Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol 28:4074-4080, 2010
31. Chlebowski RT: Breast cancer risk reduction: Strategies for women at increased risk. Annu Rev Med 53:519-540, 2002
32. Holmes MD, Chen WY, Feskanich D, et al: Physical activity and survival after breast cancer diagnosis. JAMA 293:2479-2486, 2005 (Pubitemid 40705729)
33. Pierce JP, Stefanick ML, Flatt SW, et al: Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 25:2345-2351, 2007 (Pubitemid 46999205)